Crinetics Pharmaceuticals Inc (CRNX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -95.547 | -64.95 | -28.998 | -33.415 | -47.041 | -40.28 | -46.621 | -43.448 |
Return on Equity (%) | 194.036 | 86.281 | -37.348 | -36.358 | -51.606 | -42.982 | -50.571 | -50.157 |
Return on Invested Capital (%) | 199.802 | 86.487 | -39.69 | -38.969 | -52.61 | -43.189 | -52.395 | -53.623 |
Operating Margin (%) | -1020.034 | -447.384 | -1116.763 | -4226.488 | -103960.563 | -9985.25 | -3460.376 | -5345.851 |
Net Profit Margin (%) | -1021.902 | -447.775 | -1116.763 | -4226.488 | -103960.563 | -9985.25 | -3460.376 | -5345.851 |
Book Value Per Share | -0.174 | -0.254 | 1.326 | 0.968 | 1.301 | 3.458 | 3.093 | 4.68 |
Earnings Per Share | -0.169 | -0.155 | -0.224 | -0.416 | -0.569 | -1.121 | -1.603 | -1.862 |
Cash Per Share | 0.341 | 0.24 | 0.372 | 0.333 | 0.717 | 2.091 | 0.319 | 0.477 |
Working Capital Per Share | 0.322 | 0.242 | 1.313 | 0.95 | 1.287 | 3.424 | 3.104 | 4.602 |
Operating Profit Per Share | 0.017 | 0.035 | 0.02 | 0.01 | 0.001 | 0.011 | 0.046 | 0.035 |
EBIT Per Share | -0.169 | -0.155 | -0.224 | -0.416 | -0.569 | -1.121 | -1.603 | -1.862 |
EBITDA Per Share | -0.169 | -0.155 | -0.224 | -0.416 | -0.569 | -1.121 | -1.603 | -1.862 |
Free Cash Flow Per Share | -0.166 | -0.152 | -0.219 | -0.42 | -0.574 | -1.126 | -1.596 | -1.831 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 1,17M | 1,55M | 24,06M | 24,26M | 33M | 47,6M | 53,88M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 53,88M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -1716.872 | N/A | N/A | N/A | -10384.375 | N/A | N/A |
Net Profit Margin (%) | N/A | -1716.872 | N/A | N/A | N/A | -10457.813 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 3,54B |
Ratio cours/bénéfice | -16,52 |
Ratio prix/ventes | 882,68 |
Ratio prix/liquidités | 64,56 |
Ratio prix/valeur comptable | 6,57 |
Rendement de dividende | - |
Actions en circulation | 92,74M |
Volume moyen (1 semaine) | 1,21M |
Volume moyen (1 mois) | 1,21M |
Variation sur 52 semaines | 2,99% |
Plus haut sur 52 semaines | 62,53 |
Plus bas sur 52 semaines | 35,51 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales